IN2014CH00269A - - Google Patents

Info

Publication number
IN2014CH00269A
IN2014CH00269A IN269CH2014A IN2014CH00269A IN 2014CH00269 A IN2014CH00269 A IN 2014CH00269A IN 269CH2014 A IN269CH2014 A IN 269CH2014A IN 2014CH00269 A IN2014CH00269 A IN 2014CH00269A
Authority
IN
India
Prior art keywords
retigabine
present application
modification
relates
crystalline
Prior art date
Application number
Other languages
English (en)
Inventor
Srinivasulu Rangineni
Sunitha Vyala
Satish Kumar Vujjini
Ramesh Chakka
Original Assignee
Reddy’S Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy’S Lab Ltd Dr filed Critical Reddy’S Lab Ltd Dr
Priority to IN269CH2014 priority Critical patent/IN2014CH00269A/en
Publication of IN2014CH00269A publication Critical patent/IN2014CH00269A/en

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN269CH2014 2014-01-21 2014-01-21 IN2014CH00269A (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN269CH2014 IN2014CH00269A (ru) 2014-01-21 2014-01-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN269CH2014 IN2014CH00269A (ru) 2014-01-21 2014-01-21

Publications (1)

Publication Number Publication Date
IN2014CH00269A true IN2014CH00269A (ru) 2015-08-14

Family

ID=54393600

Family Applications (1)

Application Number Title Priority Date Filing Date
IN269CH2014 IN2014CH00269A (ru) 2014-01-21 2014-01-21

Country Status (1)

Country Link
IN (1) IN2014CH00269A (ru)

Similar Documents

Publication Publication Date Title
IN2014CH00247A (ru)
EA201691582A1 (ru) Новые фармацевтические препараты
MX2019015744A (es) Composiciones farmaceuticas.
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
EP3102554A4 (en) Conversion of 2,3-butanediol to butadiene
MX2020009444A (es) Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion.
GEP20196974B (en) A novel crystalline form of a benzimidazole derivative and a preparation method thereof
MX2016015464A (es) Composicion farmaceutica oral de isotretinoina.
MX2017015137A (es) Composicion farmaceutica oral de dosis diaria de isotretinoin.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
IN2013MU03641A (ru)
IN2013MU00646A (ru)
EP3212620A4 (en) Process for the preparation of apixaban and intermediates thereof
IN2014MU00455A (ru)
PH12020550871A1 (en) Process for the preparation of opicapone and intermediates thereof
EP3229791A4 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
IN2014CH00840A (ru)
MA40312A (fr) Composition pharmaceutique orale d'isotrétinoïne
MX2016009667A (es) Forma cristalina alfa del compuesto a monobenzoato y método de preparación de la misma y composición farmacéutica que comprende la misma.
PL3236764T3 (pl) Sposób wytwarzania kompozycji przyprawowych
MA40447A (fr) Composition pharmaceutique orale d'isotrétinoïne
GB2559718B (en) Novel crystalline form of tribenuron-methyl, process for preparation and use thereof
IL237572A0 (en) Process and intermediates for the preparation of dastinib
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
IN2013MU02528A (ru)